标题
Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress
作者
关键词
Mild Cognitive Impairment, International Working Group, Lewy Body Dementia, Heart Fatty Acid Binding Protein, Behavioural Variant Frontotemporal Dementia
出版物
Molecular Diagnosis & Therapy
Volume 21, Issue 1, Pages 13-22
出版商
Springer Nature
发表日期
2016-10-13
DOI
10.1007/s40291-016-0241-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
- (2017) James K. Lui et al. JOURNAL OF ALZHEIMERS DISEASE
- Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort
- (2016) Jeffrey L. Dage et al. Alzheimers & Dementia
- Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
- (2016) Ramon Casanova et al. Alzheimers & Dementia
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
- (2016) Carlo Wilke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain
- (2016) Philipp A. Jaeger et al. Molecular Neurodegeneration
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis
- (2015) Ross W. Paterson et al. JOURNAL OF NEUROLOGY
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
- (2015) Wendy E. Heywood et al. Molecular Neurodegeneration
- Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
- (2014) Martina Sattlecker et al. Alzheimers & Dementia
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
- (2014) Kristin R Wildsmith et al. Molecular Neurodegeneration
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration
- (2013) Carole S. Scherling et al. ANNALS OF NEUROLOGY
- Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma
- (2013) Sanna Neselius et al. BRAIN INJURY
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
- (2013) Ming-Jang Chiu et al. HUMAN BRAIN MAPPING
- The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease
- (2013) Tao Wang et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
- (2013) Eugenia Trushina et al. PLoS One
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- (2012) Michal J. Figurski et al. Alzheimers & Dementia
- β-Amyloid Dynamics in Human Plasma
- (2012) Yafei Huang et al. ARCHIVES OF NEUROLOGY
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
- (2012) James D. Doecke ARCHIVES OF NEUROLOGY
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
- (2012) W. T. Hu et al. NEUROLOGY
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
- (2012) Maria Björkqvist et al. PLoS One
- Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
- (2011) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Plasma A and PET PiB binding are inversely related in mild cognitive impairment
- (2011) D. P. Devanand et al. NEUROLOGY
- Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
- (2010) A.C. Kroksveen et al. Journal of Proteomics
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
- (2009) Holly D. Soares et al. Annals of the New York Academy of Sciences
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- No correlation between time-linked plasma and CSF Aβ levels
- (2009) Nathalie Le Bastard et al. NEUROCHEMISTRY INTERNATIONAL
- Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2008) Oskar Hansson et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started